tiprankstipranks
Trending News
More News >
Faes Farma SA (ES:FAE)
BME:FAE

Faes Farma (FAE) Price & Analysis

Compare
18 Followers

FAE Stock Chart & Stats

€4.97
€0.00(0.00%)
At close: 4:00 PM EST
€4.97
€0.00(0.00%)

Faes Farma News

FAE FAQ

What was Faes Farma SA’s price range in the past 12 months?
Faes Farma SA lowest stock price was €3.27 and its highest was €4.85 in the past 12 months.
    What is Faes Farma SA’s market cap?
    Faes Farma SA’s market cap is €1.55B.
      When is Faes Farma SA’s upcoming earnings report date?
      Faes Farma SA’s upcoming earnings report date is Feb 27, 2026 which is in 67 days.
        How were Faes Farma SA’s earnings last quarter?
        Currently, no data Available
        Is Faes Farma SA overvalued?
        According to Wall Street analysts Faes Farma SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Faes Farma SA pay dividends?
          Faes Farma SA pays a Semiannually dividend of €0.033 which represents an annual dividend yield of 3.6%. See more information on Faes Farma SA dividends here
            What is Faes Farma SA’s EPS estimate?
            Faes Farma SA’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Faes Farma SA have?
            Faes Farma SA has 316,223,940 shares outstanding.
              What happened to Faes Farma SA’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Faes Farma SA?
              Currently, no hedge funds are holding shares in ES:FAE
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Faes Farma Stock Smart Score

                5
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                37.24%
                12-Months-Change

                Fundamentals

                Return on Equity
                14.89%
                Trailing 12-Months
                Asset Growth
                19.41%
                Trailing 12-Months

                Company Description

                Faes Farma SA

                Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.

                Faes Farma (FAE) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Almirall
                Grifols
                LABORATORIO REIG JOFRE
                Laboratorios Farmaceuticos Rovi
                Pharma Mar SA

                Options Prices

                Currently, No data available
                ---
                Popular Stocks